Tau-targeting therapies for Alzheimer disease
EE Congdon, EM Sigurdsson - Nature Reviews Neurology, 2018 - nature.com
Alzheimer disease (AD) is the most common form of dementia. Pathologically, AD is
characterized by amyloid plaques and neurofibrillary tangles in the brain, with associated …
characterized by amyloid plaques and neurofibrillary tangles in the brain, with associated …
The intersection of amyloid beta and tau at synapses in Alzheimer's disease
TL Spires-Jones, BT Hyman - Neuron, 2014 - cell.com
The collapse of neural networks important for memory and cognition, including death of
neurons and degeneration of synapses, causes the debilitating dementia associated with …
neurons and degeneration of synapses, causes the debilitating dementia associated with …
Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer's disease
Neuropathological and in vivo studies have revealed a tight relationship between tau
pathology and cognitive impairment across the Alzheimer's disease spectrum. However, tau …
pathology and cognitive impairment across the Alzheimer's disease spectrum. However, tau …
Autophagy flux in CA1 neurons of Alzheimer hippocampus: Increased induction overburdens failing lysosomes to propel neuritic dystrophy
M Bordi, MJ Berg, PS Mohan, CM Peterhoff… - Autophagy, 2016 - Taylor & Francis
Defective autophagy contributes to Alzheimer disease (AD) pathogenesis although
evidence is conflicting on whether multiple stages are impaired. Here, for the first time, we …
evidence is conflicting on whether multiple stages are impaired. Here, for the first time, we …
Autophagy failure in Alzheimer's disease—locating the primary defect
Autophagy, the major degradative pathway for organelles and long-lived proteins, is
essential for the survival of neurons. Mounting evidence has implicated defective autophagy …
essential for the survival of neurons. Mounting evidence has implicated defective autophagy …
Incipient Alzheimer's disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses
EM Blalock, JW Geddes, KC Chen… - Proceedings of the …, 2004 - National Acad Sciences
The pathogenesis of incipient Alzheimer's disease (AD) has been resistant to analysis
because of the complexity of AD and the overlap of its early-stage markers with normal …
because of the complexity of AD and the overlap of its early-stage markers with normal …
Engineered nucleic acids encoding a modified erythropoietin and their expression
First worldwide family litigation filed litigation Critical https://patents. darts-ip. com/? family=
46147671&utm_source= google_patent&utm_medium= platform_link&utm_campaign …
46147671&utm_source= google_patent&utm_medium= platform_link&utm_campaign …
Cholinergic system during the progression of Alzheimer's disease: therapeutic implications
Alzheimer's disease (AD) is characterized by a progressive phenotypic downregulation of
markers within cholinergic basal forebrain (CBF) neurons, frank CBF cell loss and reduced …
markers within cholinergic basal forebrain (CBF) neurons, frank CBF cell loss and reduced …
Autophagy, amyloidogenesis and Alzheimer disease
RA Nixon - Journal of cell science, 2007 - journals.biologists.com
Autophagy is the sole pathway for organelle turnover in cells and is a vital pathway for
degrading normal and aggregated proteins, particularly under stress or injury conditions …
degrading normal and aggregated proteins, particularly under stress or injury conditions …
Glutaredoxin systems
CH Lillig, C Berndt, A Holmgren - Biochimica et Biophysica Acta (BBA) …, 2008 - Elsevier
Glutaredoxins utilize the reducing power of glutathione to maintain and regulate the cellular
redox state and redox-dependent signaling pathways, for instance, by catalyzing reversible …
redox state and redox-dependent signaling pathways, for instance, by catalyzing reversible …